Invention Grant
- Patent Title: Assays and methods relating to the treatment of melanoma
-
Application No.: US15105192Application Date: 2014-12-19
-
Publication No.: US10174385B2Publication Date: 2019-01-08
- Inventor: Rhoda M. Alani , Byungwoo Ryu
- Applicant: TRUSTEES OF BOSTON UNIVERSITY
- Applicant Address: US MA Boston
- Assignee: TRUSTEES OF BOSTON UNIVERSITY
- Current Assignee: TRUSTEES OF BOSTON UNIVERSITY
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Agent Ronald I. Eisenstein; Nicole D. Kling
- International Application: PCT/US2014/071456 WO 20141219
- International Announcement: WO2015/095686 WO 20150625
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886
Abstract:
The technology described herein relates to assays and methods for the diagnosis, prognosis, and/or treatment of melanoma, e.g. relating to measuring the level of neurophilin-2 (NRP-2) mRNA expressed in melanoma cells. In some embodiments, the level of NRP-2 can be normalized to the level of Melan-A (MART) mRNA.
Public/Granted literature
- US20160312300A1 ASSAYS AND METHODS RELATING TO THE TREATMENT OF MELANOMA Public/Granted day:2016-10-27
Information query
